المؤلفون: David Azria, Olivier Riou, Esat Mahmut Ozsahin, Jean-Léon Lagrange, S. Clippe, Sophie Gourgou, Pascal Fenoglietto, Florence Castan, Françoise Mornex, Claire Lemanski, Andrew Kramar, Christophe Hennequin, Céline Bourgier, Tan Dat Nguyen, Eric Lartigau, Yazid Belkacemi, Sofia Rivera, André Pèlegrin, K Peignaux, Youlia M. Kirova, Georges Noël

المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut du Cancer de Montpellier (ICM), Institut Jean Godinot [Reims], UNICANCER, Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Curie [Paris], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Gustave Roussy (IGR), Neuro-oncologie, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre Paul Strauss, CRLCC Paul Strauss, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Université Lille Nord de France (COMUE)-UNICANCER, Michel-Avella, Amandine

المصدر: EBioMedicine
EBioMedicine, 2015, 2 (12), pp.1965-1973. ⟨10.1016/j.ebiom.2015.10.024⟩
Ebiomedicine, vol. 2, no. 12, pp. 1965-1973
EBioMedicine, Vol 2, Iss 12, Pp 1965-1973 (2015)
EBioMedicine, Elsevier, 2015, 2 (12), pp.1965-1973. ⟨10.1016/j.ebiom.2015.10.024⟩

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, lcsh:Medicine, Apoptosis, Radiation Tolerance, Adult, Aged, Aged, 80 and over, Apoptosis/radiation effects, Biomarkers, Tumor, Breast Neoplasms/complications, Breast Neoplasms/diagnosis, CD8-Positive T-Lymphocytes/immunology, CD8-Positive T-Lymphocytes/metabolism, Female, Fibrocystic Breast Disease/diagnosis, Fibrocystic Breast Disease/epidemiology, Fibrosis, Humans, Incidence, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Proportional Hazards Models, Radiotherapy, Adjuvant/adverse effects, Recurrence, Risk Factors, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Multicenter trial, Breast Fibrosis, medicine, Clinical endpoint, Lymphocytes, 030304 developmental biology, 0303 health sciences, lcsh:R5-920, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Radiation, Intention-to-treat analysis, Radiotherapy, business.industry, Proportional hazards model, Incidence (epidemiology), lcsh:R, Cancer, Dose-Response Relationship, Radiation, General Medicine, medicine.disease, 3. Good health, Surgery, Radiation therapy, 030220 oncology & carcinogenesis, Breast fibrosis, Lymphocyte, business, lcsh:Medicine (General), Prediction, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Research Article

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71d8d1e527b5896912d3dbd49ec4a26
https://hal.umontpellier.fr/hal-02338826/file/main.pdf